Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation in Healthcare (IMSH 2020).
Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare (IMSH 2020) in San Diego from January 19 to January 22.
Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, is teaming with Siemens Healthineers to perform a live LAAC procedure at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 symposium being held in San Francisco September 25-29.
Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies will be showcasing its uniquely realistic VIST® One TEE transesophageal echocardiography simulation solution at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2019, held in San Francisco’s Moscone Center September 25-29.
Introduction to Health Systems brings transparency, flexibility and predictability; opens new opportunities for clinicians to rapidly deploy simulation training for new and existing endovascular therapies.
